Meta Platforms, Inc. (Nasdaq: META) today reported financial results for the quarter ended September30, 2025. https://mma.prnewswire.com/media/1673006/Meta_Logo.jpg “We had a strong quarter for our business and our community,” said Mark Zuckerberg, Meta founder and CEO. “Meta Superintelligence Labs is off to a great start and we continue to lead the industry in AI glasses. If we […]

Hamilton Beach Brands Holding Company (NYSE:HBB) announced today that it will release its 2025 third quarter financial results and file its 10-Q for the quarter ended September 30, 2025, after the market close on Wednesday, November 5, 2025. The Company will host a conference call on Wednesday, November 5, 2025, to discuss its results. Conference

Q3 revenue growth of 12% year-over-year Q3 net income of $30.6 million and non-GAAP net income of $67.8 million Q3 net income margin of 11%; adjusted EBITDA margin of 42% Raising revenue and adjusted EBITDA guidance for 2025 Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today reported results for the

MYR Group Inc. Announces Third Quarter and First Nine Months 2025 Results GlobeNewswire October 29, 2025 THORNTON, Colo., Oct. 29, 2025 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR” or the “Company”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and

Net Loss of $(56.3) million, EPS of $(0.64) Operating Earnings of $38.5 million, Operating EPS of $0.44 Quarterly Dividend of $0.3225 Beacon Financial Corporation (NYSE: BBT) (the “Company”) today announced a net loss of $(56.3) million, or $(0.64) per basic share, for the third quarter of 2025, compared to net income of $22.0 million, or

Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company whose mattresses promise to give you “less pain, better sleep,”will report third quarter 2025 financial results on Tuesday, November 4, 2025 at approximately 4:05 p.m. ET. The Company will hold a conference call that day at 4:30 p.m. ET to review the financial results. https://mma.prnewswire.com/media/639182/Purple_mattress_logo.jpg

— Total revenue of $261.9 million — Net income of $46.8 million — Net cash provided from operations of $77.7 million — New York City Department of Transportation began expansion of the red-light program through the execution of a change order to the existing contract — Stock repurchase approval expansion — Revising 2025 full year

Poster Presentation on VENTURE Study Results Evaluating Impact of VK2735 on Prediabetes and Cardiometabolic Status Additional Poster Presentations Scheduled for American Heart Association Scientific Sessions 2025 Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company's VK2735 obesity

— Net Sales of $78 million in the Defense end market, up over 47% year over year — Net Income of $137 million, 19.8% of Net Sales — Achieved Adjusted EBITDA margin of 37% despite challenging demand environment — Net Cash Provided by Operating Activities of $228 million — Adjusted Free Cash Flow of $184

Double-Digit Revenue Growth Drives 20%+ EPS Growth and 30%+ Cash Flow Growth Rollins, Inc. (NYSE:ROL) (“Rollins” or the “Company”), a premier global consumer and commercial services company, reported unaudited financial results for the third quarter of 2025. https://mma.prnewswire.com/media/2257900/Rollins___Logo.jpg Key Highlights — Third quarter revenues were $1 billion, an increase of 12.0% over the third quarter